Article Title: FDA Panel Split on Safety of Long-Acting Testosterone
Author: Megan Brooks
Date of Publication: April 18, 2013
An advisory panel to the US Food and Drug Administration (FDA) was split today on the question of whether or not testosterone undecanoate intramuscular injection (Aveed, Endo Pharma Solutions) is a safe testosterone replacement therapy, given reports of severe post-injection reactions.
Note: This MedScape article requires that you setup a free account to view the article.